We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Bisphenols exposure and non-alcoholic fatty liver disease: from environmental trigger to molecular pathogenesis
Summary
This review synthesizes epidemiological and mechanistic evidence linking bisphenol A and its substitutes (BPS, BPF) to non-alcoholic fatty liver disease, showing that these plasticizer chemicals disrupt hepatic fat metabolism, impair insulin signaling, activate inflammatory pathways, and interact synergistically with high-fat diets and other plasticizers to drive liver disease progression.
Bisphenols (BPs), including bisphenol A (BPA) and its substitutes (BPS, BPF), are ubiquitous environmental contaminants with emerging links to metabolic disorders. This review synthesizes current evidence on the role of BP exposure in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), a global health crisis affecting 25% of adults worldwide. Epidemiological studies reveal significant positive associations between urinary/serum BP levels and NAFLD risk, particularly in males, with maternal exposure correlating to transgenerational metabolic dysfunction. Mechanistically, BPs disrupt hepatic lipid homeostasis by activating PPAR-γ and suppressing fatty acid oxidation while concurrently inducing insulin resistance via impaired IRS-1/PI3K/Akt signaling. Oxidative stress, NLRP3 inflammasome activation, and gut-liver axis perturbations further exacerbate steatosis and inflammation. Co-exposure with phthalates or high-fat diets amplifies hepatotoxicity, highlighting synergistic environmental risks. Critically, developmental and sex-specific susceptibility underscores the need for tailored interventions. We propose preventive strategies to mitigate NAFLD progression, including BP avoidance and policy reforms. This work bridges gaps between environmental epidemiology and molecular toxicology, emphasizing BPs as modifiable drivers of metabolic liver disease.